title: Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review.
abstract: The optimal type and duration of antifungal therapy for localized aspergillosis in cardiac transplant recipients is unclear. We report the case of a patient who had persistent invasive pulmonary aspergillosis despite prolonged treatment with amphotericin B. A combined approach using antifungal therapy and surgery appears effective for localized pulmonary disease. Aspergillar infection in solid organ transplant recipients is reviewed.
authors.affiliation: Division of Infectious Disease, University of Utah Medical Center, Salt Lake City, Utah 84132.
authors.forename: J M
authors.initials: JM
authors.lastname: Mayer
authors.forename: L
authors.initials: L
authors.lastname: Nimer
authors.forename: K
authors.initials: K
authors.lastname: Carroll
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D001228:Aspergillosis / Q000209:etiology* / Q000628:therapy; D001232:Aspergillus fumigatus / Q000187:drug effects / Q000302:isolation & purification; D016027:Heart Transplantation; D006801:Humans; D016867:Immunocompromised Host; D008172:Lung Diseases, Fungal / Q000209:etiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications
chemical_list: D000666:Amphotericin B